The tumor area activated various proliferation and metastasis-related signaling pathways (such as MK, SPP1, SEMA3, MIF, and VEGF) and immunosuppression-related signaling pathway (GALECTIN) (Fig. 6D). This evidence concerns the gene SPP1 and neoplasm.